跳转至内容
Merck
所有图片(1)

主要文件

AP502P

Sigma-Aldrich

山羊抗人Igκ链抗体,HRP偶联,吸附物种

Chemicon®, from goat

别名:

Anti-Human Ig HRP, HRP Goat Anti-Human Ig

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

goat

质量水平

偶联物

peroxidase conjugate

抗体形式

affinity purified immunoglobulin

抗体产品类型

secondary antibodies

克隆

polyclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

ELISA: suitable

运输

wet ice

靶向翻译后修饰

unmodified

一般描述

抗体分子通常包含与一对重链共价结合的两条免疫球蛋白轻链。免疫球蛋白轻链有两种类型,用希腊字母κ和λ表示。κ和λ轻链的长度约为250个氨基酸,平均质量约为25 kDa。在免疫球蛋白群体中发现的κ与λ的比例因物种而异。

特异性

与人κ轻链反应。可吸收带有λ轻链的人骨髓瘤蛋白和小鼠免疫球蛋白。

应用

ELISA:1:4,000-1:8,000。

最佳工作稀释度必须由最终用户进行确定。
山羊抗人Igκ链抗体,HRP偶联物,吸附物种可检测人Igκ链水平&已发表&经验证可用于ELISA。

外形

通过亲和色谱法对与琼脂糖共价连接的κ轻链的合并人Igs进行纯化。液体50%甘油/50%PBS,pH7.4。

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hyori Kim et al.
Oncology letters, 25(6), 236-236 (2023-05-08)
Anti-CD19 chimeric antigen receptor (CAR)-T cells have improved the outcomes of patients with B cell leukemia and lymphoma. However, their applications and positive outcomes remain limited. CAR-T cells are currently restricted to autologous blood as their source and their use
Ki Hyun Kim et al.
PLoS pathogens, 15(2), e1007375-e1007375 (2019-02-02)
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease localized to China, Japan, and Korea that is characterized by severe hemorrhage and a high fatality rate. Currently, no specific vaccine or treatment has been approved for this disease.
Ramin Dubey et al.
eLife, 9 (2020-05-21)
R-spondins (RSPOs) amplify WNT signaling during development and regenerative responses. We previously demonstrated that RSPOs 2 and 3 potentiate WNT/β-catenin signaling in cells lacking leucine-rich repeat-containing G-protein coupled receptors (LGRs) 4, 5 and 6 (Lebensohn and Rohatgi, 2018). We now
Jessica N Peel et al.
The Journal of clinical investigation, 134(8) (2024-03-12)
BACKGROUNDWeakly virulent environmental mycobacteria (EM) can cause severe disease in HLA-DRB1*15:02 or 16:02 adults harboring neutralizing anti-IFN-γ autoantibodies (nAIGAs). The overall prevalence of nAIGAs in the general population is unknown, as are the penetrance of nAIGAs in HLA-DRB1*15:02 or 16:02

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门